DC24206 |
KN-93 HCl
Featured
|
Potent, cell permeable inhibitor of CaM kinase II (IC50 = 0.37 μM). |
|
DC7251 |
AM 281
Featured
|
Potent, selective CB1 cannabinoid receptor antagonist/inverse agonist (Ki values are 12 and 4200 nM for CB1 and CB2 receptors respectively). Increases locomotor activity following systemic administration in vivo. Analog of SR141716A (Ki = 14 nM). |
|
DC7704 |
Poziotinib
Featured
|
Poziotinib, is an orally bioavailable, quinazoline-based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity. |
|
DC12421 |
PP1 inhibitor C31 |
PP1 inhibitor C31 is a 1E7-03 analog and protein phosphatase 1 (PP1) targeting small molecule with Kd of 1.88 uM, inhibits Ebola virus (EBOV) transcription and replication. |
|
DC5007 |
pp1
Featured
|
PP1 is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM. |
|
DC8742 |
PP121 |
PP-121 is a multi-targeted inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC50 of 2 nM, 8 nM, 10 nM, 12 nM, 14 nM and 18 nM, also inhibits DNA-PK with IC50 of 60 nM. |
|
DC9931 |
PP2 analog
Featured
|
PP2 analog is the analog of PP2,a Src family kinase inhibitor. |
|
DC5008 |
PP2(AGL 1879)
Featured
|
PP2 is Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM, ~100-fold less potent to EGFR, inactive for ZAP-70, JAK2 and PKA. |
|
DC7482 |
Torkinib (PP242)
Featured
|
PP242 is a selective mTOR inhibitor with IC50 of 8 nM; targets both mTOR complexes with >10- and 100-fold selectivity for mTOR than PI3Kδ or PI3Kα/β/γ, respectively; also showed slightly weaker activity against BRD4 (Kd= 1.7 uM). |
|
DC23712 |
PPARα activator compound 3 |
PPARα activator compound 3 is a specific PPAR activator that selectively up-regulates PPARα transcriptional activity, leading to PPARα target gene expression both in vitro and in vivo. |
|
DC23517 |
PPBI |
PPBI is a novel potent, selective, full M1 muscarinic agonist with EC50 of 5, 8, and 21 nM for human, rat, and mouse M1 receptors, respectively. |
|
DC21525 |
PPI-2458 |
PPI-2458 is potent, specific, irreversible methionine aminopeptidase-2 (MetAP-2) inhibitor with IC50 of 0.2 nM, inhibits growth inhibition of HFLS-RA and HUVEC with IC50 of 0.04 nM. |
|
DC7483 |
PPQ-102
Featured
|
PPQ-102 is a potent CFTR inhibitor which can completely inhibited CFTR chloride current with IC 50approximately 90 nM. |
|
DC21943 |
PPTN trifluoroacetate salt |
PPTN is a potent, highly specific amtagonist of P2Y14 receptor with Ki of 0.4 nM in functional assays. |
|
DC21942 |
PPTN |
PPTN is a potent, highly specific amtagonist of P2Y14 receptor with Ki of 0.4 nM in functional assays. |
|
DC22059 |
PptT inhibitor 8918 |
PptT inhibitor 8918 (Compound 8918) is a mycobactericidal amidino-urea compound that targets phosphopantetheinyl transferase (PptT, IC50=2.5 uM), shows an MIC90 of 3.1 uM against Mtb H37Rv. |
|
DC2083 |
PQ401
Featured
|
PQ 401 is an IGF-1R inhibitor with IC50 of <1 μM. |
|
DC23868 |
PQC 083 |
PQC 083 is a novel nerve growth factor (NGF) antagonist with IC50 of 7.0 uM, functionally inhibits NGF's effects on PC12 cell differentiation. |
|
DC10767 |
PQR530
Featured
|
PQR530 is a selective, orally bioavailable, potent dual PI3K/mTORC1/2 inhibitor. |
|
DC20221 |
PQR620
Featured
|
PQR620 is a novel potent and selective brain penetrant inhibitor of mTORC1/2. |
|
DC20510 |
PR5-LL-CM01 |
PR5-LL-CM01 is a novel selective, small-molecule inhibitor of PRMT5 methyltransferase with IC50 of 7.5 uM. |
|
DC7252 |
PR-619
Featured
|
PR-619 is a broad-range DUB inhibitor with potential for further development as a chemotherapeutic agent in cancer therapy. |
|
DC7280 |
Pracinostat(SB939)
Featured
|
Pracinostat(SB939) is a potent pan-HDAC inhibitor with IC50 of 40-140 nM with exception for HDAC6; has no activity against the class III isoenzyme SIRT I. |
|
DC12202 |
Pradefovir mesylate (Remofovir mesylate)
Featured
|
Pradefovir mesylate is a good substrate for liver CYP3A4. Pradefovir is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with a Km of 60 μM. |
|
DC9359 |
Pralatrexate
Featured
|
Pralatrexate(Folotyn) is an antifolate, and structurally a folate analog. |
|
DC11526 |
Praliciguat
Featured
|
Praliciguat (IW-1973, IW1973) is a potent, orally available sGC stimulator that concentration-dependently increases the production of cGMP with EC50 of 267 nM. |
|
DC10263 |
Pralidoxime (chloride) |
Pralidoxime is an antidote to organophosphate pesticides and chemicals. |
|
DC8970 |
Pramipexole Base |
Pramipexole is a dopamine agonist of the non-ergoline class indicated for treating Parkinson's disease (PD) and restless legs syndrome (RLS). |
|
DC3151 |
Pramipexole dihydrochloride |
Pramipexole is a partial/full D2S, D2L, D3, D4, receptor agonist with a Ki of 3.9, 2.2, 0.5, 5.1 nM. |
|
DCAPI1305 |
Pramiracetam |
Pramiracetam |
|